Topics
Gliomas | Treatment | Targeted therapy | Pamiparib
Home > Publications > Topics > Gliomas > Treatment > Targeted therapy > Pamiparib
Schiff D, Ye X, Li J, Ellingson BM, Wen PY, Walbert T, Campian J,
Burt Nabors L, Ozer BH, Desai A, Omuro A, Desideri S, Danda N,
Grossman S, Bindra RS.
Phase I/II and
Window-of-Opportunity Study of Pamiparib and Metronomic
Temozolomide for Recurrent IDH Mutant Gliomas.
Neuro
Oncol. 2025 Oct 16:noaf246. doi:
10.1093/neuonc/noaf246. PMID:
41099363. Interventional
study˰
ˍ